Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Revolution Beauty reaches settlement with former CEO

(Sharecast News) - Make-up company Revolution Beauty has reached a settlement with co-founder and former chief executive Adam Minto following the delayed publication of its FY22 results and its suspension from trading during his time in the top job. Revolution Beauty and Minto have agreed to the full and final settlement of certain claims between the pair. In connection with the settlement, Minto will pay Revolution Beauty a settlement sum of £2.9m, paid in six annual installments, with the first payment of £483,333.35 due on 28 March.

The AIM-listed group said on Monday that having considered its options and legal advice received, it believes this to be "a fair settlement" for the company.

Chairman Alistair McGeorge said: "We are very pleased to have reached an agreement with Adam. This, together with the revised payment schedule agreed in December 2023 for the acquisition of Medichem, means we can now focus on the future. We look forward to providing an update on our strategy at our upcoming Capital Markets Event on 8 February 2024".

As of 0850 GMT, Revolution shares were up 3.39% at 30.50p.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

Endeavour pours first gold at Senegal mine
(Sharecast News) - Endeavour Mining said it had poured first gold from the Sabodala-Massawa BIOX Expansion project in Senegal on April 18.
Wood Group creates new chief strategy officer role
(Sharecast News) - Consulting and engineering business Wood Group has created a new executive role of chief strategy officer to look after things like sustainability and corporate development.
AstraZeneca makes progress with two breast cancer treatments
(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.
Kosmos Energy refinances reserve-based lending facility
(Sharecast News) - Kosmos Energy announced the refinancing of its reserve-based lending (RBL) facility on Monday, with its final maturity now set for December 2029.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.